Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Haynes

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
British Journal of Cancer|June 21, 2012
Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohortsE M Bessell, G Bouliotis, S Armstrong, et al.
Leukemia|June 22, 1999
Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAGJ L Byrne, E Dasgupta, M Pallis, et al.
Bone Marrow Transplantation|March 21, 2000
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaJ L Byrne, C Stainer, G Cull, et al.
British Journal of Haematology|April 8, 1998
Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8G M Cull, J M Timms, A P Haynes, et al.
British Journal of Haematology|May 3, 2000
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicityG M Cull, A P Haynes, J L Byrne, et al.
The British Journal of Ophthalmology|May 19, 2004
Treatment of Erdheim-Chester disease with cladribine: a rational approachC Myra, L Sloper, P J Tighe, et al.
British Journal of Haematology|October 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trialA Khwaja, D C Linch, A H Goldstone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2015
Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohortM J Bishton, R Hubbard, R Witherall, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
British Journal of Cancer|June 21, 2012
Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohortsE M Bessell, G Bouliotis, S Armstrong, et al.
Leukemia|June 22, 1999
Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAGJ L Byrne, E Dasgupta, M Pallis, et al.
Bone Marrow Transplantation|March 21, 2000
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaJ L Byrne, C Stainer, G Cull, et al.
British Journal of Haematology|April 8, 1998
Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8G M Cull, J M Timms, A P Haynes, et al.
British Journal of Haematology|May 3, 2000
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicityG M Cull, A P Haynes, J L Byrne, et al.
The British Journal of Ophthalmology|May 19, 2004
Treatment of Erdheim-Chester disease with cladribine: a rational approachC Myra, L Sloper, P J Tighe, et al.
British Journal of Haematology|October 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trialA Khwaja, D C Linch, A H Goldstone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2015
Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohortM J Bishton, R Hubbard, R Witherall, et al.
Pageof 5